News

Analyzing Options Activity at AeroVironment: Insights Ahead

Analyzing Options Activity at AeroVironment: Insights Ahead

Insights into AeroVironment's Options Activity

AeroVironment (NASDAQ: AVAV) is currently at the center of attention as savvy investors show a notable bearish sentiment. This trend among wealthy investors should not be overlooked by market participants. Recent tracking of public options records revealed significant activity that could indicate crucial movements for AeroVironment.

Understanding the Options Landscape

Today's scanning of options activities indicates that heavy investment actions have formed within the AeroVironment market segment. This rise in unusual options trading was evidenced by 22 unique activities being flagged, which deviates from the typical volume.

Investor Sentiment Analysis

The sentiment is notably mixed among these large investors, with approximately 50% displaying a bearish outlook, contrasted with only 31% expressing bullish signals. Among the options ranked, there are 12 puts valued at around $647,299, while the calls stand at about $681,558.

Projected Price Targets

Analyzing the volume alongside open interest provides a glimpse into potential price targets speculated by larger investors over the past three months. These whales seem focused on a price spectrum between $125.0 and $390.0 for AeroVironment.

Current Volume and Open Interest Trends

When investigating options trading, analyzing volume and open interest is essential, as it gives insights into market liquidity. By examining the surge in demand for call and put options across a set price range in the last month, traders can gauge investor interests and market sentiment.

Recent Important Options Trends

From the past 30 days, there has been noteworthy activity that riders on AeroVironment's options. Tracking this data helps in understanding the changing dynamics of the market. Below is a summary of the most significant trades observed:

Top Options Detected

Details of the largest trades highlight various investor strategies:

  • Options: CALL - A bullish sentiment with a substantial sweep, total trade amounting to $176.0K for expected expiration in 2026.
  • Options: PUT - Also a bearish position, reflecting concerns, totaling $133.9K, scheduled for 2026.
  • Options: CALL - Another bullish move, totaling $102.8K, indicates investors are betting on potential gains.

About AeroVironment

AeroVironment Inc specializes in supplying unmanned aircraft systems, high-altitude pseudo-satellites, and tactical missile systems primarily for the Department of Defense and allied government entities. Their solutions play a crucial role in security and surveillance, providing real-time observation capabilities without physical presence in the skies. The company's focus encompasses various defense technologies across air, land, sea, cyber, and space. They deliver an array of advanced capabilities, including autonomy and precision strike systems.

Current Market Position

  • Recent trading volume stands at 704,229, with the price of AVAV fluctuating by -1.1%, settling at $247.0.
  • Indicators suggest that AVAV may be nearing an oversold condition, impacting investment strategies.
  • The upcoming earnings report is anticipated within approximately 81 days, which will likely influence market perceptions.

Analyst Ratings Overview

The analytical landscape reflects a mix of opinions. During the last month, five industry analysts have provided insights, with an average target price set at $391.2 for AVAV. Various firms maintain distinct price targets based on their assessments:

  • An analyst from RBC Capital has kept an Outperform rating, aiming for $400.
  • Canaccord Genuity continues to recommend Buy with a target of $400.
  • Cantor Fitzgerald maintains an Overweight position, targeting $315.
  • Needham lowered its rating to Buy, setting a new target of $450, while Piper Sandler adjusted its outlook to Overweight with a target of $391.

Investing in options inherently carries risks but provides potential rewards for astute traders. Vigilant tracking of market movements and educational endeavors enhances trading strategies for individuals interested in AeroVironment.

Frequently Asked Questions

What is AeroVironment's stock ticker?

AeroVironment's stock is traded under the ticker AVAV on the NASDAQ.

What does AeroVironment specialize in?

AeroVironment specializes in unmanned aircraft systems and defense technologies for government agencies.

What recent activity has been noted in AeroVironment options?

There has been significant unusual options activity, with a mix of bullish and bearish sentiments among investors.

What are the projected price targets for AeroVironment stocks?

Analysts suggest price targets for AeroVironment range between $315 and $450 based on current evaluations.

How is the current market position of AeroVironment?

AeroVironment’s stock is currently showing mixed signals with a slight decrease in price, drawing attention to potential investment opportunities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 189

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 308

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 155

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 157

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 138

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 117

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

R. Scot Buell: From Oil Fields to Inner Excellence

Updated Category News Views 14

R. Scot Buell: A Catalyst in Petroleum Engineering So, here's the skinny on R. Scot Buell, a guy whose name rings bells in the petroleum engineering corridors. The Inner Circle's tip of the hat to him as a Pinnacle Professional Member Inner Circle of Excellence isn't just a ceremonial bash—it stamps on a career that has gone all out in the energy sector. What's this...

Continue Reading
Forbes Honors Check Point Software as Premier Cybersecurity Employer

Updated Category News Views 133

Check Point Software Achieves Remarkable Recognition Check Point Software Technologies Ltd. (NASDAQ: CHKP) has recently earned a prestigious accolade from Forbes, being named one of the World’s Best Employers for the fifth consecutive year. This recognition highlights the company's commitment not just to cybersecurity, but to creating an inspiring workplace for its...

Continue Reading
Coinbase CEO Predicts Bitcoin Will Reach $18 Trillion Market Value

Updated Category News Views 154

Bitcoin's Remarkable Ascent Towards $18 Trillion U.Today reports that Bitcoin (BTC) is increasingly seen as a superior monetary asset compared to traditional reserves like gold. The CEO of Coinbase (NASDAQ: COIN) emphasizes that Bitcoin has unique advantages that may lead it to achieve a staggering market valuation of over $18 trillion. Currently, Bitcoin's market value...

Continue Reading
Certara Unveils Innovative Non-Animal Testing Solution for Drug Developers

Updated Category News Views 127

Introducing Certara's Groundbreaking Non-Animal Navigator Solution In an exciting development for the pharmaceutical industry, Certara, Inc. (Nasdaq: CERT), a leading force in model-informed drug development, has launched its innovative Non-Animal Navigator solution. This new initiative is designed to help biopharmaceutical companies transition towards reduced reliance on...

Continue Reading
Dr. Gerard van Belle Takes Helm as Director of Science

Updated Category News Views 394

Dr. Gerard van Belle Appointed Director of Science at Lowell Observatory Dr. Gerard van Belle has officially taken the role of Director of Science at Lowell Observatory, managing a team tasked with groundbreaking astronomical exploration and innovation. Leading a New Era in Astronomy In this pivotal position, van Belle is set to guide a diverse group of astronomers and...

Continue Reading